Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching

BACKGROUND: An essential component of evaluating potential modified risk tobacco products is to determine how consumers use the product and resulting effects on biomarkers of toxicant exposure. STUDY DESIGN: Cigarette smokers (n=391) recruited in Minnesota and Oregon were randomised to either snus o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatsukami, Dorothy K, Severson, Herbert, Anderson, Amanda, Vogel, Rachael Isaksson, Jensen, Joni, Broadbent, Berry, Murphy, Sharon E, Carmella, Steven, Hecht, Stephen S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785094/
https://www.ncbi.nlm.nih.gov/pubmed/25991608
http://dx.doi.org/10.1136/tobaccocontrol-2014-052080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785094/
https://www.ncbi.nlm.nih.gov/pubmed/25991608
http://dx.doi.org/10.1136/tobaccocontrol-2014-052080

Ejemplares similares